Huan He
Changchun, 130033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 26, 2026
Genome-Wide Association Study Dissects the Genetic Architecture of Pericarp Traits in Fresh-Eating Maize.
Journal: Plants (Basel, Switzerland)
Published: November 13, 2025
Burden of Cardiovascular Diseases Attributable to Hypertension in Population Aged 60 Years or Older from 1990 to 2040 across BRICS-plus Countries (Egypt, Ethiopia, Iran, Saudi Arabia, United Arab Emirates, Brazil, Russia, India, China, and South Africa).
Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: May 03, 2025
Multiple low-dose radiation ameliorates type-2 diabetes mellitus via gut microbiota modulation to activate TLR4/MyD88/NF-κB pathway.
Journal: BMC endocrine disorders
Published: September 19, 2024
Advances in the relationship between AP-1 and tumorigenesis, development and therapy resistance.
Journal: Discover oncology
Published: July 24, 2024
A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1).
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 01, 2024
MCM2 is involved in subtyping and tamoxifen resistance of ERα-positive breast cancer by acting as the downstream factor of ERα.
Journal: Biotechnology journal
Published: October 16, 2023
Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells.
Journal: BMC cancer
Published: May 01, 2023
Silencing TAB182 inhibits cell EMT, migration and invasion by downregulating EGFR in A549 NSCLC cells.
Journal: Molecular biology reports
Published: September 07, 2022
ERα and ERβ Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions.
Journal: Frontiers in endocrinology
Published: April 27, 2022
Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor.
Journal: Cancer letters
Published: December 15, 2020
Last Updated: 09/26/2026